Andrew P Levy Selected Research

Cardiovascular Diseases (Cardiovascular Disease)

08/2008	Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.
03/2008	Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
11/2007	Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.
11/2006	Application of pharmacogenomics in the prevention of diabetic cardiovascular disease: mechanistic basis and clinical evidence for utilization of the haptoglobin genotype in determining benefit from antioxidant therapy.
02/2005	Haptoglobin phenotype, sleep-disordered breathing, and the prevalence of cardiovascular disease: the Sleep Heart Health Study.
05/2004	Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.
08/2003	Haptoglobin polymorphism is a risk factor for cardiovascular disease in patients with obstructive sleep apnea syndrome.
06/2003	Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease.
12/2002	Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.

9	Cardiovascular Diseases (Cardiovascular Disease) 08/2008 - 12/2002
4	Myocardial Infarction 01/2007 - 09/2003
1	Diabetes Mellitus 03/2008
1	Type 2 Diabetes Mellitus (MODY) 02/2008
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2007
1	Hemorrhage 07/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 06/2007
1	Infection 04/2007
1	Heart Failure 09/2005
1	Hypertrophy 07/2005
1	Sleep Apnea Syndromes (Sleep Apnea) 02/2005
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2005
1	Atherosclerosis (Atheroma) 04/2004
1	Coronary Disease (Coronary Heart Disease) 02/2004
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2004
1	Macular Degeneration (Age-Related Maculopathy) 11/2003
1	Obstructive Sleep Apnea 08/2003

21	HaptoglobinsIBA 08/2008 - 12/2002
2	Vitamin E FDA Link 02/2008 - 11/2007
2	Hemoglobins (Hemoglobin)IBA 07/2007 - 06/2003
1	AntioxidantsIBA 03/2008
1	Scavenger Receptors (Scavenger Receptor)IBA 07/2007
1	IronIBA 11/2004
1	VitaminsIBA 04/2004